People ascending to high altitude regions are at risk for a variety of health problems, commonly including acute mountain sickness (AMS), high-altitude cerebral oedema (HACE) and high-altitude pulmonary oedema (HAPE) etc. Increasing travel to mountainous terrains has brought light to several other medical problems as well. It has been well recognized that a hypercoagulable state exists when a person is exposed to high altitude environment.
A multidisciplinary team approach to diagnosis and management of interstitial lung diseases (ILD) is considered gold standard and an integral part of ILD management and guidelines. The accurate diagnosis and management of individuals with ILDs poses an interesting challenge in clinical practice. This is a single center retrospective review of electronic patient letters and multidisciplinary team (MDT) records spanning a five and half year time period.
Background: Primary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormally beating cilia. In these patients levels of nasal nitric oxide (nNO) are lower than those observed in healthy subjects.
Objectives: We recorded the nNO levels in PCD patients in order to use those nNO measurements in the screening and identification of patients with symptoms suggestive of disease PCD disease.
Tracheo-bronchial amyloidosis is a rare airway disorder that can be a challenge for the limitations of treatment, recurrence and complications. We report the complex clinical course of a patient with symptomatic localized tracheo-bronchial amyloidosis. Different procedures were performed due to recurrent amyloid over a period of three and half years from the first endoscopic resection.
Background: Asthma represents one of the most common medical conditions encountered during pregnancy, which may seriously affect its outcome.
Objective: To evaluate the outcome of asthma attacks during pregnancy and the role medications play for appropriate asthma management.
Methods: In this prospective study, we present our 15 years' experience from hospitalization in ICU of 11 pregnant women (13-29 weeks of gestation) with severe asthma.
The current National Institute for Health and Care Excellence (NICE) chronic obstructive pulmonary disease (COPD) guidelines were updated in 2010, reflecting clinical evidence available at that time. Since the guidelines were written, a growing body of evidence has demonstrated enhanced Bronchodilation with LABA/LAMA in fixed-dose combinations (FDCs) versus single component agents (the standard of care) in moderate to severe COPD.
